Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Conferences | Events

Do you want to make the move from diagnostics to BiognostiX?

publication date: Mar 18, 2014
 | 
author/source: Kapler Communications

FFEI at the Hauser Forum in Cambridge

A symposium focusing on the results of a 3-year EU-funded programme to design a novel fibre-based microfluidic technology to enables rapid and simple point-of-use diagnostic testing has been held at the Hauser Forum, Cambridge, UK

The BiognostiX consortium, headed by experts at FFEI Life Science, brought together academic, research and commercial partners from five European countries. The symposium Leading the way from diagnostics to BiognostiX, featured presentations from each, accelerating the process of disseminating the proof of principle data generated as part of the project...

George Hutchinson, Director, FFEI Life Science, said, We are at a very exciting stage in the development of the programme and we are keen to meet new partners who have a need for the BiognostiX technology. Rapid, low cost, multiplex diagnostic testing on this simple device is an appealing option for a wide range of applications, in veterinary, agri-food and human diagnostic, for example. 

The desired assay biochemistry, microfluidics and a novel particle technology platform are combined on a BiognostiX Chip. Composed of a fibre-based substrate, each BiognostiX Chip is mechanically treated to create a microfluidic channel pattern. Reagents are deposited using fluid-jet technologies to deliver picolitre quantities of capture complex Immuno-Ink into specific zones of the channels.  

The simplicity and flexibility of the manufacturing process allows for changes in chip configuration during the assay development process. The number of microfluidic channels can be varied depending on assay requirements and the residence time of the sample can be adjusted to control the interaction time between the sample and the Immuno-Ink. The output of the immunoassays can be quantified using densiometric, colorimetric or fluorometric techniques. Once the biochemistry and chip are optimised, they are then fixed for simple, low-cost manufacture. 


more about BiognostiX


more about FFEI Life Science




 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

Today's Picks

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.